N. Oliveira

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

A. Tinker, A. deFazio, C. Gilks, 2016, British Journal of Cancer.

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance

A. Tinker, C. Gilks, T. Westbrook, 2015, Oncogene.

EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface

Y. He, J. Coward, M. Adams, 2014, Oncogene.